Intact Investment Management’s Grace Therapeutics GRCE Stock Holding History

Intact Investment Management’s Portfolio GRCE Stock Details GRCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,021	Closed	-$81K	–	264
2018 Q3	$81K	Hold	1,021	–	–	﹤0.01%	255
2018 Q2	$37K	Hold	1,021	–	–	﹤0.01%	261
2018 Q1	$64K	Sell	1,021 -833	-45%	-$41.1K	﹤0.01%	248
2017 Q4	$106K	Sell	1,854 -10	-0.5%	-$672	﹤0.01%	262
2017 Q3	$158K	Hold	1,864	–	–	0.01%	248
2017 Q2	$152K	Hold	1,864	–	–	0.01%	249
2017 Q1	$152K	Hold	1,864	–	–	0.01%	256
2016 Q4	$154K	Hold	1,864	–	–	0.01%	261
2016 Q3	$206K	Hold	1,864	–	–	0.01%	267
2016 Q2	$157K	Hold	1,864	–	–	0.01%	261
2016 Q1	$173K	Hold	1,864	–	–	0.01%	266
2015 Q4	$287K	Sell	1,864 -944	-34%	-$111K	0.01%	217
2015 Q3	$452K	Hold	2,808	–	–	0.02%	188
2015 Q2	$485K	Hold	2,808	–	–	0.02%	191
2015 Q1	$782K	Hold	2,808	–	–	0.03%	163
2014 Q4	$755K	Hold	2,808	–	–	0.03%	172
2014 Q3	$1.09M	Sell	2,808 -57	-2%	-$26.8K	0.04%	129
2014 Q2	$1.51M	Buy	+2,865	New	+$1.37M	0.06%	89
2014 Q1	–	Sell	-3,333	Closed	-$2.08M	–	250
2013 Q4	$2.08M	Buy	+3,333	New	+$2.73M	0.1%	70

Other funds holding GRCE

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

PVI

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

KJHP

K.J. Harrison & Partners Toronto, Ontario, Canada $706M AUM 48.92% 1-Year Est. Return

Intact Investment Management's GRCE Position: Q4 2018 in Review

Intact Investment Management sold out of Grace Therapeutics (GRCE) in Q4 2018, closing a stake of 1,021 shares — an estimated $81K sold.

Intact Investment Management first reported a position in GRCE in Q4 2013 and held it in 19 quarters. The position peaked at $2.08M in Q4 2013. 13 funds tracked by Wall St. Rank hold GRCE as of Q4 2018.

Intact Investment Management reported no remaining Grace Therapeutics position as of Q4 2018 after selling out during the quarter.
Intact Investment Management sold 1,021 Grace Therapeutics shares in Q4 2018, an estimated $81K.
Intact Investment Management first reported a position in Grace Therapeutics in Q4 2013 and held it in 19 quarters.
Intact Investment Management's Grace Therapeutics position peaked at $2.08M in Q4 2013.
13 funds tracked by Wall St. Rank held Grace Therapeutics as of Q4 2018.

Based on Intact Investment Management's 13F filing for Q4 2018, filed 22 Jan 2019.